-+ 0.00%
-+ 0.00%
-+ 0.00%
Specific Biologics raises USD 35 million in Series A with Lumira Ventures participation
Share
Listen to the news
Specific Biologics raises USD 35 million in Series A with Lumira Ventures participation
  • Specific Biologics closed an oversubscribed USD 35 million Series A financing led by Hatteras Venture Partners.
  • Existing investors Lumira Ventures and adMare BioInnovations participated alongside new life sciences investors.
  • The biotechnology company develops precision gene-editing therapies targeting disease-causing DNA repeat expansions.
  • Proceeds will advance its lead Dualase therapy through initial clinical biomarker proof-of-concept in patients with C9ORF72-associated ALS.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lumira Capital Investment Management Inc published the original content used to generate this news brief on November 02, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending